Small prostate size and high grade disease-biology or artifact?

Journal of Urology

Volumn 185, Issue 6, 2011, Pages 2108-2111

  Liu, Jen Jane ^a   Brooks, James D ^a   Ferrari, Michelle ^a   Nolley, Rosie ^a   Presti Jr , Joseph C ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

pathology; prostate specific antigen; prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER GRADING; CANCER SIZE; DIGITAL RECTAL EXAMINATION; DISEASE SEVERITY; GLEASON SCORE; MORPHOMETRICS; PATHOLOGIST; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE SIZE;

AGED; ARTIFACTS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; ORGAN SIZE; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 79955796559     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2011.02.053     Document Type: Article

References (10)

1. S.J. Freedland, W.B. Isaacs, and E.A. Platz Prostate size and risk of high grade, advanced prostate cancer and biochemical progression after radical prostatectomy: a SEARCH database study J Clin Oncol 23 2005 7546
2. A. Briganti, F.K.H. Chun, and N. Suardi Prostate volume and adverse prostate cancer features: fact not artifact Eur J Cancer 43 2007 2669
3. N.R. Newton, S. Phillips, and S.S. Chang Smaller prostate size predicts high grade prostate cancer at final pathology J Urol 184 2010 930
4. G.W. Chodak, N.J. Vogelzang, and R.J. Caplan Independent prognostic factors in patients with metastatic (stage D2) prostate cancer: the Zoladex Study Group JAMA 265 1991 618
5. I.M. Thompson, D.P. Ankerst, and C. Chi Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower JAMA 294 2005 66
6. M.C. Benson, I.S. Whang, and A. Pantuck Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer J Urol 147 1992 815
7. C.S. Elliott, R. Shinghal, and J.C. Presti The performance of prostate specific antigen, prostate specific antigen density and transition zone density in the era of extended biopsy schemes J Urol 179 2008 1756
8. J.E. McNeal, A.A. Villers, and E.A. Redwine Capsular penetration in prostate cancer Significance for natural history and treatment Am J Surg Pathol 14 1990 240
9. J.E. McNeal, A.A. Villers, and E.A. Redwine Histologic differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate Cancer 66 1990 1225
10. T.A. Stamey, J.E. McNeal, and C.M. Yemoto Biological determinants of cancer progression in men with prostate cancer JAMA 281 1999 1395